Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials

<p>Abstract</p> <p>Background</p> <p>Evidence that chemotherapy improves survival and quality of life in patients with stage IIIB & IV non small cell lung cancer (NSCLC) is based on large randomized controlled trials. The purpose of this study was to determine eligi...

Full description

Bibliographic Details
Main Authors:	Dadasovich Ryan, Vardy Janette, Beale Philip, Boyer Michael, Clarke Stephen J
Format:	Article
Language:	English
Published:	BMC 2009-04-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/9/130

Similar Items

Barriers to non-small cell lung cancer trial eligibility
by: Jeffrey J. Hardesty, et al.
Published: (2018-03-01)

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer
by: Xiaoyan Si, et al.
Published: (2020-11-01)

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
by: Katsuyuki Hotta, et al.
Published: (2011-01-01)

The effect of prior cancer on non‐small cell lung cancer trial eligibility
by: Michael Herman, et al.
Published: (2021-07-01)

The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol
by: Dhillon Haryana M, et al.
Published: (2012-12-01)

THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY
by: Elihu Estey
Published: (2013-07-01)

Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial
by: Matjaz Zwitter, et al.
Published: (2011-01-01)

Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials
by: Zhang Y, et al.
Published: (2013-11-01)

NCAA academic eligibility standards for competition in Division III
by: Winkler, Chris Charles
Published: (2012)

Advances of maintenance chemotherapy on advanced non-small cell lung cancer
by: Xinghao AI, et al.
Published: (2008-02-01)

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials
by: Mitesh J. Borad, Kelly K. Curtis, Hani M. Babiker, Martin Benjamin, Raoul Tibes, Ramesh K. Ramanathan, Karen Wright, Amylou C. Dueck, Gayle Jameson, Daniel D. Von Hoff
Published: (2012-01-01)

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials
by: He X, et al.
Published: (2015-08-01)

Advance of second-line chemotherapy in advanced non-small cell lung cancer
by: Li ZHANG
Published: (2008-02-01)

Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer
by: Zhao Chuan, et al.
Published: (2006-12-01)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
by: Mani Akhtari, et al.
Published: (2016-06-01)

Cytotoxic chemotherapy in advanced non-small cell lung cancer
by: G.V. Scagliotti, et al.
Published: (2005-12-01)

Lung Cancer Care Before and After Medicare Eligibility
by: Marco D. Huesch MBBS, PhD, et al.
Published: (2016-05-01)

Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
by: Tang N, et al.
Published: (2016-07-01)

Phase III trials of standard chemotherapy with or without bevacizumab for ovarian cancer: a meta-analysis.
by: Mingyi Zhou, et al.
Published: (2013-01-01)

Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation
by: Jing Li, et al.
Published: (2020-01-01)

Final Overall Survival Results from the FLAURA Trial: a Phase III Study on Osimertinib in EGFRMutated Advanced Non-small Cell Lung Cancer
by: Yue WANG, et al.
Published: (2020-06-01)

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
by: Gridelli C, et al.
Published: (2018-05-01)

Generating Medical Logic Modules for Clinical Trial Eligibility
by: Parker, Craig G.
Published: (2005)

Chemotherapy of Advanced Non-small Cell Lung Cancer in Elderly Patients
by: Xin NIE, et al.
Published: (2009-03-01)

Chemotherapy in Advanced Non-Small Cell Lung Cancer: Present and Future
by: Yu ZHANG
Published: (2017-03-01)

Chemotherapy for advanced non-small cell lung cancer in the elderly population
by: Fábio Nasser Santos, et al.

Customized chemotherapy based on <it>epidermal growth factor receptor</it> mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial
by: Fujita Shiro, et al.
Published: (2012-05-01)

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
by: Veronica Rendo, et al.
Published: (2020-12-01)

Perioperative chemotherapy of stage Ⅲ N2 non-small cell lung cancer
by: Shun LU, et al.
Published: (2008-10-01)

Chemotherapy on nonresectable stage Ⅲ N2 non-small cell lung cancer
by: Li ZHANG
Published: (2008-10-01)

Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study
by: Babu KG, et al.
Published: (2014-06-01)

Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study.
by: Yusuke Takagi, et al.
Published: (2013-01-01)

Relationship between Expression of β-tubulin-Ⅲ Plus Stathmin in Advanced Non-Small Cell Lung Cancer and its Sensitivity to Venorelbine Chemotherapy
by: Xiaolin PU, et al.
Published: (2009-01-01)

Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial
by: Soo Jin Park, et al.
Published: (2020-05-01)

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
by: Forder Peta M, et al.
Published: (2011-04-01)

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
by: Ismaili Mohammed, et al.
Published: (2010-06-01)

The Changes of the first-line Chemotherapy on Advanced non-small Cell Lung Cancer
by: Baohui HAN, et al.
Published: (2008-04-01)

Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer
by: Sheng YANG, et al.
Published: (2016-05-01)

Nationwide Estimation of Eligibility for Endovascular Thrombectomy Based on the DAWN Trial
by: Keon-Joo Lee, et al.
Published: (2018-05-01)

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
by: Wang H, et al.
Published: (2020-05-01)